109322 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines; Interleukins [IL] Interleukin-7 (IL-7)
Methods of preparing T cells for T cell therapy
#302Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
#303Method of producing natural killer cells and composition for treating cancer
#304T Cell Expansion Method
#305Compositions and methods for preventing and treating graft versus host disease
#306COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME
#307Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#308METHODS FOR MANUFACTURING T CELLS EXPRESSING OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS
#309TRANSPOSON SYSTEM AND METHODS OF USE
#310Method for amplifying CD8+T cells and cell subpopulations thereof in-vitro
#311Method to obtain lymphoid progenitors
#312Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#313METHOD FOR GENERATING T CELLS PROGENITORS
#314Natural killer cells
#315MR1 restricted T cell receptors for cancer immunotherapy
#316Method for producing CD8alpha+beta+ cytotoxic t cells
#317METHODS OF TRANSDUCING AND EXPANDING IMMUNE CELLS AND USES THEREOF
#318Method for inducing amplification of type I NKT cells in vitro
#319VC-CAR molecule and use thereof in removing HIV-1 infected cells
#320METHODS AND KITS FOR GENERATING MIMETIC INNATE IMMUNE CELLS FROM PLURIPOTENT STEM CELLS
#321PRODUCTION OF ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY
#322Genetic re-engineering of immune cells to improve metabolic fitness for immunotherapy
#323Method of producing natural killer cells and composition for treating cancer
#324METHODS OF GENERATING NATURAL KILLER CELLS
#325Veto cells generated from memory T cells
#326Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
#327Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#328Process of expanding T cells
#329GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#330Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#331Methods for manufacturing T cells
#332TRANSPOSON SYSTEM AND METHODS OF USE
#333Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells
#334Generation of HPV-specific T-cells
#335PLATFORM FOR ACTIVATION AND EXPANSION OF VIRUS-SPECIFIC T-CELLS
#336T cell compositions
#337TRANSPOSON SYSTEM AND METHODS OF USE
#338Ex vivo generation of γδ Foxp3regulatory T cells and therapeutic uses thereof
#339Ex vivo generation of MHCII restricted CD4FOXP3regulatory T cells and therapeutic uses thereof
#340Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells
#341GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#342Method for generating progenitor t cells from stem and/or progenitor cells and use of same
#343GENETICALLY ENGINEERED CELLS AND METHODS OF MAKING THE SAME
#344Process for T cell expansion
#345PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER (PINK) CELLS FOR TREATMENT OF GLIOBLASTOMA
#346KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#347Bovine serum composition and method for culturing cells using said bovine serum composition as additive
#348Methods of making and using embryonic mesenchymal progenitor cells
#349Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using
#350MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#351NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF
#352Method of manufacturing dual-specific T-cells for use in cancer immunotherapy
#353BK virus specific T cells
#354Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#355Generating HPV antigen-specific cells from a naive T cell population
#356Methods for directed differentiation of pluripotent stem cells to immune cells
#357Semi-static cell culture
#358Generation of HPV-specific T-cells
#359Methods and materials for expanding antigen-specific T cells in culture
#360Improved method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist
#361Genetically modified anti-third party central memory T cells and use of same in immunotherapy
#362Methods of transplantation and disease treatment
#363Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
#364Pepmixes to generate multiviral CTLs with broad specificity
#365Methods for the production of TCRγδ T cells
#366Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
#367Ex vivo NK cell differentiation from CD34 hematopoietic cells
#368METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#369Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells
#370EX VIVO DEVELOPMENT, EXPANSION AND IN VIVO ANALYSIS OF A NOVEL LINEAGE OF DENDRITIC CELLS
#371Composition and Methods of Using Umbilical Cord Lining Stem Cells
#372Methods and compositions for modulating T-GM cell function
#373Modulated immunodominance therapy
#374KIF20A epitope peptides for TH1 cells and vaccines containing the same
#375Methods for improving the efficacy and expansion of immune cells
#376Methods of Preparing T Cells for T Cell Therapy
#377Human progenitor T-cells into NK cells
#378ARYL HYDROCARBON RECEPTOR DISRUPTION AND ENHANCEMENT
#379Multi-lineage hematopoietic precursor cell production by genetic programming
#380MODULATED IMMUNODOMINANCE THERAPY
#381Development Of Natural Killer Cells And Functional Natural Killer Cell Lines
#382NKT-like cell subpopulation and method of using the same in the treatment of tumor
#383METHODS OF EXPANDING EX VIVO NATURAL KILLER T (NKT) CELLS AND THERAPEUTIC USES THEREOF
#384Method for reconstructing immune function using pluripotent stem cells
#385METHODS OF GENERATING NATURAL KILLER CELLS
#386Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses
#387METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT
#388Cell expansion
#389UNIVERSAL DONOR CHIMERIC ANTIGEN RECEPTOR CELLS
#390Methods of making chimeric antigen receptor-expressing cells
#391METHOD FOR PREPARING NK CELLS
#392Methods for stimulating antigen-specific T cell responses
#393Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use
#394Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#395NATURAL KILLER CELLS AND USES THEREOF
#396Industrial preparations of natural killer (NK) cells and injections containing NK cells
#397KIF20A epitope peptides for TH1 cells and vaccines containing the same
#398In vitro culture conditions for T-cell acute lymphoblastic leukemia/lymphoma
#399Methods of generating natural killer cells
#400PROCESS FOR T CELL EXPANSION
#401Process of expanding T cells
#402EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#403PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY
#404Populations of hematopoietic progenitors and methods of enriching stem cells therefor
#405Method of generating tumor-specific T cells
#406Producing human CD34+CD7+CD5+CD1a− progenitor T cells and method of treatment
#407Antigen-specific central-memory T cell preparations having high CD4+ fraction
#408Generation of NK cells and NK-cell progenitors
#409Generation of natural killer cells and lymphoid tissue inducer-like (LTi-like) NK-22 cells
#410Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
#411Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
#412Method for developing natural killer cells from stem cells
#413Method for activating helper T cell
#414Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
#415Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment
#416Method for reconstructing immune function using pluripotent stem cells
#417Methods of treatment using ex vivo expansion of cord blood T cells
#418HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE
#419Methods of generating natural killer cells
#420Identification of antigenic peptides from multiple myeloma cells
#421Identification of antigenic peptides from multiple myeloma cells
#422Identification of antigenic peptides from multiple myeloma cells
#423Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#424CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using
#425Generating a mature NKT cell from a reprogrammed somatic cell with a T-cell antigen receptor α-chain region rearranged to uniform Va-Ja in a NKT-cell specific way
#426Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses
#427Identification of antigenic peptides from multiple myeloma cells
#428Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells
#429Methods for Production of Regulatory T Cells and Uses Thereof
#430Development of natural killer cells and functional natural killer cell lines
#431Methods and compositions for inducing hematopoietic cell differentiation